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Background: Human Immunodeﬁciency Virus type 1 (HIV-
1) and type 2 (HIV-2) may case a severe immunodeﬁciency in
humans (AIDS). However HIV-2 is more frequently associated
with lower levels of transmission and disease progression,
compared with HIV-1 infections. The role of nef gene in vivo
during the development of AIDS has been clearly demon-
strated in simian immunodeﬁciency virus infected Rhesus
macaques model, but the determinants which play a role
in the pathogenesis of HIV are relatively poorly understood.
However, even less is known about the role of nef in HIV-2
infections.
Methods: In this study, it was analyzed the variation
of 48 nef gene sequences, obtained from samples taken
between 1994 and 2009, corresponding to 17 HIV-2-infected
individuals with different clinical stages of infection. The
sequences obtained by Nested PCR were classiﬁed by phylo-
genetic analysis and the functional protein motifs, described
as important in CD4 and MHC-I downregulation and in viral
infectivity were also analyzed.
Results: In all individuals were identiﬁed nef sequences
from group A of HIV-2, which encoded possible functional
and complete protein. There was a greater conserva-
tion of residues in the Nef sequences of individuals in
the symptomatic stage (63%), comparatively to individuals
in the asymptomatic stage (19%). While some functional
motifs (MGxxxS1, DDDD93, RR137 and DD205) and also
residues (G128, I141 and L142) remained conserved, others
(YSRF39, LRAR21, PxxP101, EE185) revealed changes dur-
ing the follow-up period. The PxxP motif exhibited wide
inter-individual variation in vivo from an HIV-1-like tetra-
proline motif (PxxP)3 to disruption of the minimal core
PxxPLR motif. The disruption was observed in 11 sequences
exclusively from asymptomatic individuals (p = 0.021). The
sequence motif variation towards tetra-proline conﬁgura-
tion was observed in 2 symptomatic individuals during time
of infection. The results also revealed the existence of a
negative selective pressure, as well as codons under positive
pressure in the sequences.
Conclusion: In this HIV-2-infected individuals studied, it
was observed a need for a greater degree of Nef protein con-
servation in a symptomatic phase. Sequences altered and
potentially critical for the Nef function in vivo, in earlier
stages of infection, may contribute at some level to a dif-
ferent pattern in viral pathogenesis and disease progression.
doi:10.1016/j.ijid.2010.02.2023
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Background: HIV-1 cell entry commonly uses, in addition
o CD4, one of the chemokine receptors CCR5 or CXCR4 as
oreceptor. Human immunodeﬁciency virus type 1 (HIV-1)
solates can be classiﬁed phenotypically according to the
rimary coreceptor used to enter the cells. Third variable
egion (V3- loop) of the gp120 subunit of the HIV-1 enve-
ope protein has been identiﬁed as a major determinant of
oreceptor usage. Knowledge of coreceptor usage is crit-
cal for monitoring disease progression and for supporting
herapy with the novel drug class of coreceptor antagonists.
redictive methods for inferring coreceptor usage based on
he third V3- loop region can provide us with these monitor-
ng facilities while avoiding expensive phenotypic assays. In
his study we applied an artiﬁcially neural network on phys-
ochemical data, derived from V3- loop sequence to predict
oreceptor usage of viral isolate.
Methods: At ﬁrst authors has collected two reliable set of
ata that deﬁne the biochemical and structural conditions
f co receptor usage of virus. In the next step we have devel-
ped an ANN models to predict virus coreceptor usage and
ompare the results of ANN models with MLR model. In the
NN model, two levels of 1 and 2 are used as output vector
r goal, respectively for R4 and R5 and the physiochemical
spects are input variables, also it was in MLR model.
Results: The process of training and testing of this new
odel is done using a set of collected data. ANN model with
2 = 0.99 and RMSE = 15.18 in training stage and R2 = 0.91 and
MSE = 187.8 in testing stage is superior in predicting the
oreceptor usage. Several statistical and graphical criterions
re used to check the accuracy of the model.
Conclusion: The coreceptor usage values predicted by
he ANN model satisfactorily compared with the measured
ata. The predicted values were also compared with those
redicted using linear regression model. The presented
ethodology in this modeling is a new approach in estimat-
ng coreceptor usage and can be combinedwith othermodels
nd empirical methods of coreceptor usage determination.
oi:10.1016/j.ijid.2010.02.2024
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linical and immunologic response of HIV patients on dif-
erent ART regimens at Gondar University Hospital (GUH). Ergete
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Background: As HIV treatment program expands in
esource poor countries, antiretroviral drug selection is
